+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ancobon"

Cryptococcosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cryptococcosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 90 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Ancobon market is a segment of the infectious diseases drugs market that focuses on the treatment of fungal infections. It is composed of antifungal drugs, which are used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. These drugs are used to treat both superficial and systemic fungal infections, and are available in both oral and intravenous formulations. The Ancobon market is a highly competitive space, with a number of large pharmaceutical companies vying for market share. Some of the major players in the Ancobon market include Pfizer, Merck, Novartis, AstraZeneca, and GlaxoSmithKline. These companies offer a range of antifungal drugs, including azoles, echinocandins, and polyenes. Show Less Read more